| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.035 | 0.8 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.8 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |